AM-Pharma

AM-Pharma, once a Pfizer takeover target, flunks phase 3 kidney injury trial
Fierce Biotech
Thu, 10/20/22 - 10:35 am
AM-Pharma
clinical trials
kidney injury
Pfizer
Years after Pfizer passed on a buyout option, AM-Pharma finds a new partner for its kidney drug
Endpoints
Wed, 09/8/21 - 11:12 am
Pfizer
AM-Pharma
kidney failure
As it preps Phase III kidney trial on its own, AM-Pharma raises €116M series C
BioCentury
Tue, 07/16/19 - 11:03 am
Pfizer
AM-Pharma
acute kidney injury
Pfizer Trying To Overcome Patent Cliff
Seeking Alpha
Wed, 05/20/15 - 06:30 pm
Pfizer
patent cliff
AM-Pharma
M&A
Pfizer continues its deal spree with a $600M option pact to buy AM-Pharma
Fierce Biotech
Tue, 05/12/15 - 11:54 am
Pfizer
M&A
AM-Pharma